NASDAQ: NRC - National Research Corporation

Доходность за полгода: -44.58%
Дивидендная доходность: +2.93%
Сектор: Healthcare

График акции National Research Corporation


О компании National Research Corporation

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

подробнее
The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

IPO date 1997-10-10
ISIN US6373722023
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 4.68
Дивиденд ао 0.12
Сайт https://www.nrchealth.com
Цена ао 13.94
Изменение цены за день: 0% (10.78)
Изменение цены за неделю: -9.87% (11.96)
Изменение цены за месяц: -27.31% (14.83)
Изменение цены за 3 месяца: -36.33% (16.93)
Изменение цены за полгода: -44.58% (19.45)
Изменение цены за год: -68.63% (34.36)
Изменение цены за 3 года: -72.62% (39.37)
Изменение цены за 5 лет: -69.21% (35.01)
Изменение цены с начала года: -36.85% (17.07)

Недооценка

Название Значение Оценка
P/S 2.89 6
P/BV 13.21 1
P/E 16.68 7
EV/EBITDA 11.42 7
Итого: 6.25

Эффективность

Название Значение Оценка
ROA, % 19.44 6
ROE, % 61.77 10
Итого: 6.5

Дивиденды

Название Значение Оценка
Div yield, % 2.93 7.33
DSI 0.8571 8.57
Итого: 5.93

Долг

Название Значение Оценка
Debt/EBITDA 1.52 7
Итого: 6.8

Импульс роста

Название Значение Оценка
Доходность Revenue, % 7.32 1
Доходность Ebitda, % -17.88 0
Доходность EPS, % -28.01 0
Итого: 0.2

Институционалы Объем Доля, %
Kayne Anderson Rudnick Investment Management LLC 2881464 12.08
Blackrock Inc. 1065585 4.47
Morgan Stanley 943710 3.96
Vanguard Group Inc 934644 3.92
Conestoga Capital Advisors, LLC 780806 3.27
Dimensional Fund Advisors LP 636402 2.67
QV Investors Inc. 395102 1.66
Renaissance Technologies, LLC 373584 1.57
Geode Capital Management, LLC 356305 1.49
State Street Corporation 342475 1.44

ETFДоля, %Доходность за год, %Дивиденды, %
iShares Morningstar Small-Cap Growth ETF 0.01365 596.94 0.72598
iShares Morningstar Small-Cap ETF 0.00669 391.25 1.60498
0.01494.11.17



Руководитель Должность Оплата Год рождения
Mr. Michael D. Hays Founder, CEO, President & Director 131.11k 1955 (70 лет)
Ms. Helen L. Hrdy Chief Customer Officer 291.51k 1965 (60 лет)
Mr. Jon Boumstein Chief Delivery Officer N/A
Megan Charko Senior Manager of Content Marketing N/A
Mr. Christophe Louvion Chief Product & Technology Officer N/A 1973 (52 года)
Mr. Andy Monnich Chief Corporate Development Officer N/A 1976 (49 лет)
Mr. Jason Hahn Chief Revenue Officer N/A 1972 (53 года)
Ms. Linda Stacy Secretary N/A
Ms. Vinitha Ramnathan Chief Product Officer

Адрес: United States, Lincoln. NE, 1245 Q Street - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.nrchealth.com